Page last updated: 2024-08-17

isosorbide dinitrate and Genetic Predisposition

isosorbide dinitrate has been researched along with Genetic Predisposition in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's7 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dries, DL; McNamara, D; Rame, JE; Sabolinski, ML; Tam, SW; Worcel, M; Wu, AH1
Puckrein, G; Yancy, CW1
Echols, MR; Yancy, CW1
Hoover, EL1
Sade, RM1
Korsten, MA; Ma, JJ; Mei, QB; Qui, B1

Reviews

1 review(s) available for isosorbide dinitrate and Genetic Predisposition

ArticleYear
Isosorbide dinitrate-hydralazine combination therapy in African Americans with heart failure.
    Vascular health and risk management, 2006, Volume: 2, Issue:4

    Topics: Black or African American; Disease Progression; Drug Combinations; Endothelium, Vascular; Genetic Predisposition to Disease; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Nitric Oxide; Oxidative Stress; Patient Selection; Severity of Illness Index; Treatment Outcome; Vasodilator Agents

2006

Other Studies

6 other study(ies) available for isosorbide dinitrate and Genetic Predisposition

ArticleYear
Dysfunctional corin i555(p568) allele is associated with impaired brain natriuretic peptide processing and adverse outcomes in blacks with systolic heart failure: results from the Genetic Risk Assessment in Heart Failure substudy.
    Circulation. Heart failure, 2009, Volume: 2, Issue:6

    Topics: Black or African American; Cardiovascular Agents; Double-Blind Method; Drug Combinations; Female; Gene Frequency; Genetic Predisposition to Disease; Heart Failure, Systolic; Hospitalization; Humans; Hydralazine; Immunoassay; Isosorbide Dinitrate; Kaplan-Meier Estimate; Male; Middle Aged; Multicenter Studies as Topic; Mutation; Natriuretic Peptide, Brain; Phenotype; Proportional Hazards Models; Protein Processing, Post-Translational; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Assessment; Risk Factors; Serine Endopeptidases; Treatment Outcome; United States

2009
Illuminating BiDil.
    Nature biotechnology, 2005, Volume: 23, Issue:8

    Topics: Black or African American; Drug Approval; Drug Combinations; Genetic Predisposition to Disease; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Politics; Public Policy; United States

2005
BiDil's impact.
    Nature biotechnology, 2005, Volume: 23, Issue:11

    Topics: Black or African American; Drug Approval; Drug Combinations; Genetic Predisposition to Disease; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Risk; United States

2005
There is no scientific rationale for race-based research.
    Journal of the National Medical Association, 2007, Volume: 99, Issue:6

    Topics: Biomarkers; Biomedical Research; Black or African American; Clinical Trials as Topic; Drug Combinations; Genetic Predisposition to Disease; Genetic Variation; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Prejudice; Racial Groups; United States

2007
What's right (and wrong) with racially stratified research and therapies.
    Journal of the National Medical Association, 2007, Volume: 99, Issue:6

    Topics: Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Biomedical Research; Black or African American; Drug Approval; Drug Combinations; Drug Industry; Genetic Predisposition to Disease; Genetic Variation; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Prejudice; Racial Groups; Randomized Controlled Trials as Topic; United States; United States Food and Drug Administration

2007
Susceptibility to cerulein-induced pancreatitis in inducible nitric oxide synthase-deficient mice.
    Pancreas, 2001, Volume: 23, Issue:1

    Topics: Acute Disease; Amylases; Animals; Ceruletide; Genetic Predisposition to Disease; Injections, Intraperitoneal; Isosorbide Dinitrate; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Neutrophils; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrites; Pancreatitis; Peroxidase

2001